Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Evaluate whether the S&P 500 or total market index better suits your retirement goals, considering risk, fees, and long-term growth.
28,526 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Strategy shifted roughly 411 BTC to Coinbase Prime, prompting a fresh look at its cash strategy. The move has revived...
A significant stake in Clearwater Analytics has sparked renewed interest in the company’s SaaS-driven investment acco...
Lenders are rethinking the obsession with individual loan officer output as market conditions shift toward team struc...
When Berkshire Hathaway keeps a stake in a company for decades, you want to listen. american express just showed why ...
A new era of autonomous AI agents could turbocharge voice tech leaders. Learn how agentic will supercharge soundhound...
Private exits are lagging as liquidity tightens in private markets. This report explains why the exploding secondarie...
As the Pentagon bets big on affordable, domestically produced drones, investors wonder if Red Cat Holdings can ride t...
SailPoint faced a sharp pullback after its latest results, sparking questions about growth and profitability. This ar...
Navigator (NVGS) 2025 earnings paint a picture of a niche LNG carrier operator balancing utilization, rates and lever...
Nvidia's blockbuster quarter fuels AI capex optimism, lifting Bitcoin as tech risk appetite returns. The link between...
Solv Protocol confirms a crypto exploit drained about $2.7 million from a Bitcoin yield vault, impacting roughly 10 u...